In the op-ed, David Anderson, a health insurance researcher at Duke University Margolis Center for Health Policy in Washington, D.C., and Nicholas Bagley, a professor at the University of Michigan Law School in Ann Arbor, emphasized the need for a ban on surprise billing from out-of-network providers for coronavirus treatment.
“In a coronavirus pandemic, a patient can do everything right and still face substantial surprise bills,” the authors wrote. Later, they pointed out that, “Reputable providers will appreciate that now is not the time for price gouging. But many won’t and will seek to exploit people’s medical needs for financial gain, much as they did before the coronavirus began to spread.”
The authors called on Congress to pass a temporary measure to limit out-of-network charges for patients seeking COVID-19 testing and treatment.
Some hospitals have taken their own steps to delay sending patients bills for testing and treatment of COVID-19.
View the full op-ed here.
More articles on healthcare finance:
Texas medical group files for bankruptcy
8 hospitals have closed so far this year — here’s why
Missouri town loses hospital after 100 years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
